Abstract:The gut microbiome has emerged as an important factor affecting human health and disease. The recent development of –omics approaches, including phylogenetic marker-based microbiome profiling, shotgun metagenomics, metatranscriptomics, metaproteomics, and metabolomics, has enabled efficient characterization of microbial communities. These techniques can provide strain-level taxonomic resolution of the taxa present in microbiomes, assess the potential functions encoded by the microbial community and quantify the metabolic activities occurring within a complex microbiome. The application of these meta-omics approaches to clinical samples has identified microbial species, metabolic pathways, and metabolites that are associated with the development and treatment of human diseases. These findings have further facilitated microbiome-targeted drug discovery and efforts to improve human health management. Recent in vitro and in vivo investigations have uncovered the presence of extensive drug-microbiome interactions. These interactions have also been shown to be important contributors to the disparate patient responses to treatment that are often observed during disease therapy. Therefore, developing techniques or frameworks that enable rapid screening, detailed evaluation, and accurate prediction of drug/host-microbiome interactions is critically important in the modern era of microbiome research and precision medicine. Here we review the current status of meta-omics techniques, including integrative multi-omics approaches, for characterizing the microbiome's functionality in the context of health and disease. We also summarize and discuss new frameworks for applying meta-omics approaches and microbiome assays to study drug-microbiome interactions. Lastly, we discuss and exemplify strategies for implementing microbiome-based precision medicines using these meta-omics approaches and high throughput microbiome assays.

Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside

How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

Metabonomics: a useful tool for the future surgeon

Multi-omics approaches to studying gastrointestinal microbiome in the context of precision medicine and machine learning

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Proteomics applied to pediatric medicine: opportunities and challenges

Bioinformatics and machine learning in gastrointestinal microbiome research and clinical application

An Integrated Multi-Disciplinary Perspective for Addressing Challenges of the Human Gut Microbiome

Multiomics-based strategies for taming intestinal inflammation in the neonate

Challenges and Perspective in Integrated Multi-Omics in Gut Microbiota Studies

The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders

Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease

Proteomics and the Microbiome: Pitfalls and Potential

Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

Gut microbiome-host interactions in health and disease

The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations

The gut microbiota and host health: a new clinical frontier

Advancing functional and translational microbiome research using meta-omics approaches

Integrating Omics: The Future of IBD?